×
Affiliated Organizations
  HN Medical Partners   School of Nursing   HNH Fitness   Villa Marie Claire   Simulation Learning   Haiti Health Promise
Medical Partners Offices
Cardiovascular Specialists University Orthopaedic Pulmonary Specialists Obstetrics & Gynecology North Jersey Heart North Jersey Surgical Surgical Specialistss Primary Care Specialty Assoc. Urologic Specialties Women's Health Care

List of Clinical Studies

  201-541-6312    |      info@holyname.org

COVID-19

Study Name Principal Investigator
Regeneron 6R88-COV-2040 – An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab For Hospitalized Patients with COVID-19.
Read more.
Suraj Saggar, DO
Regeneron R10933-10987-COV-2067– A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike SARS-CoV-2 Monoclonal Antibodies For the Treatment of Ambulatory Patients with COVID-19.
Read more.
Suraj Saggar, DO
PLX-COV-01 – A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase II Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX-PAD for the Treatment of Severe COVID-19.
Read more.
Suraj Saggar, DO
CD12_COVID-19 – A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients with Severe or Critical Coronavirus Disease 2019 (COVID-19).
Read more.
Benjamin De La Rosa, MD
MS200569-0026 – Merck Serono – A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of M5049 in Hospitalized Participants with COVID-19 Pneumonia
Read more.
Benjamin De La Rosa, MD
J2W-MC-PYAB - Eli Lilly – A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants with Mild to Moderate COVID-19 Illness (BLAZE-1)
Read more.
Suraj Saggar, DO
J2X-MC-PYAH – Eli Lilly – A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy with Monoclonal Antibodies in Participants with Mild to Moderate COVID-19 Illness (BLAZE-4)
Read more.
Suraj Saggar, DO
FREEDOM - Mount Sinai – COVID Anticoagulation Strategy Randomized Trial
Read more.
Thomas Birch, MD
V3011902 – Veru – Phase 3, Randomized, Placebo-Controlled, Efficacy and Safety Study of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS)
Read more.
Benjamin De La Rosa, MD